A novel model of cholesterol efflux from lipid-loaded cells

Acta Pharmacologica Sinica

Volumn 31, Issue 10, 2010, Pages 1243-1257

  Luo, Di Xian ^a,b,c   Cao, De Liang ^d   Xiong, Yan ^a   Peng, Xu Hong ^c   Liao, Duan Fang ^b,e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

ABC A1; Apo A1; atherosclerosis; caveolae; caveolin 1; cholesterol efflux; HDL; lipid loaded cells; SR B1

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CAVEOLIN 1; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI;

CAVEOLA; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL TRANSPORT; CHOLESTEROL TRANSPORT; FOAM CELL; HUMAN; INTRACELLULAR SIGNALING; MACROPHAGE; MOLECULAR MODEL; NONHUMAN; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANTIGENS, CD36; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CAVEOLAE; CAVEOLIN 1; CHOLESTEROL; FOAM CELLS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; MYOCYTES, SMOOTH MUSCLE;

EID: 77957748382     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.93     Document Type: Review

References (146)

1. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part II: clinical implications. Circulation 2004;110:2066-71.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
3. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation 2004;110:1868-73.
4. Ory DS. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ Res 2004;95:660-70.
5. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004;25:947-70.
6. von Bergmann K, Sudhop T, Lutjohann D. Cholesterol and plant sterol absorption: recent insights. Am J Cardiol 2005;96:10D-14D.
7. Martin S, Parton RG. Caveolin, cholesterol, and lipid bodies. Semin Cell Dev Biol 2005;16:163-74.
8. Fielding CJ, Fielding PE. Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev 2001;49:251-64.
9. Fielding PE, Fielding CJ. Intracellular transport of low density lipopro tein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 1996;35:14932-8.
10. Sun SW, Zu XY, Tuo QH, Zhu BY, Chen LX, Lei XY, et al. Caveolae and caveolin-1 mediated the endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol Sin 2010;31:1336-42.
11. Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are upregulated by free cholesterol and down-regulated by oxysterols in fbroblast monolayers. Proc Natl Acad Sci USA 1997;94:3753-8.
12. Fielding PE, Fielding CJ. Plasma membrane caveolae mediate the effux of cellular free cholesterol. Biochemistry 1995;34:14288-92.
13. Fielding PE, Nagao K, Hakamata H, Chimini G, Fielding CJ. A twostep mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochemistry 2000;39:14113-20.
14. Yan PK, Liao DF, Yang YZ. Influence of caveolin-1 on cholesterol effux in vascular smooth muscle cells. Chin J Arterioscler 2002;10:379-83.
15. Schlegel A, Lisanti MP. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J Biol Chem 2000;275:21605-17.
16. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 2002;54:431-67.
17. Uittenbogaard A, Smart EJ. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid trans port of cholesterol to caveolae. J Biol Chem 2000;275:25595-9.
18. Fu Y, Hoang A, Escher G, Parton RG, Krozowski Z, Sviridov D. Expression of caveolin-1 enhances cholesterol effux in hepatic cells. J Biol Chem 2004;279:14140-6.
19. Luo DX, Cheng J, Xiong Y, Li J, Xia C, Xu C, et al. Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway. Biochem Biophys Res Commun 2010;391:1693-7.
20. Brown DA. Lipid droplets: proteins foating on a pool of fat. Curr Biol 2001;11: R446-9.
21. Pol A, Luetterforst R, Lindsay M, Heino S, Ikonen E, Parton RG. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J Cell Biol 2001;152:1057-70.
22. Uittenbogaard A, Ying Y, Smart EJ. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol traffcking. J Biol Chem 1998;273:6525-32.
23. Rhainds D, Brissette L. The role of scavenger receptor class B type I (SR-BI) in lipid traffcking. defining the rules for lipid traders. Int J Biochem Cell Biol 2004;36:39-77.
24. Mulcahy JV, Riddell DR, Owen JS. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol effux. Biochem J 2004;377:741-7.
25. Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 1998;273:26338-48.
26. Frank PG, Marcel YL, Connelly MA, Lublin DM, Franklin V, Williams DL, et al. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 2002;41:11931-40.
27. Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-defcient mice. Circulation 2003;108:2258-63.
28. De La Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, Phillips MC, et al. Scavenger receptor BI (SR-BI) mediates free cholesterol fux independently of HDL tethering to the cell surface. J Lipid Res 1999;40:575-80.
29. Yancey PG, Bortnick AE, Kellner-Weibel G, De La Llera-Moya M, Phillips MC, Rothblat GH. Importance of different pathways of cellular cholesterol effux. Arterioscler Thromb Vasc Biol 2003;23:712-9.
30. Soro-Paavonen A, Westerbacka J, Ehnholm C, Taskinen MR. Metabolic syndrome aggravates the increased endothelial activation and low-grade infammation in subjects with familial low HDL. Ann Med 2006;38:229-38.
31. Stefkova J, Poledne R, Hubacek JA. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res 2004;53:235-43.
32. Oram JF, Lawn RM. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 2001;42:1173-9.
33. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 2002;277:33178-87.
34. Drobnik W, Borsukova H, Bottcher A, Pfeiffer A, Liebisch G, Schutz GJ, et al. Apo AI/ABCA1-dependent and HDL3-mediated lipid effux from compositionally distinct cholesterol-based microdomains. Traffic 2002;3:268-78.
35. Gillotte KL, Zaiou M, Lund-Katz S, Anantharamaiah GM, Holvoet P, Dhoest A, et al. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affnity and membrane penetration in the effux of cellular cholesterol and phospholipid. J Biol Chem 1999;274:2021-8.
36. Tang CK, Yang JH, Yi GH, Wang Z, Liu LS, Wan ZY, et al. Effects of oleate on ATP binding cassette transporter A1 expression and cholesterol effux in THP-1 macrophage-derived foam cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003;35:1077-82. (Pubitemid 38368297)
37. Hu YW, Ma X, Li XX, Liu XH, Xiao J, Mo ZC, et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009;204: e35-43.
38. Hao XR, Cao DL, Hu YW, Li XX, Liu XH, Xiao J, et al. IFN-gamma downregulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 2009;203:417-28.
39. Zhang C, Yin W, Liao D, Huang L, Tang C, Tsutsumi K, et al. NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs. J Lipid Res 2006;47:2055-63.
40. Neufeld EB, Stonik JA, Demosky SJ Jr, Knapper CL, Combs CA, Cooney A, et al. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem 2004;279:15571-8.
41. Smith JD, Waelde C, Horwitz A, Zheng P. Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid effux. J Biol Chem 2002;277:17797-803.
42. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol effux to highdensity lipoproteins. Proc Natl Acad Sci USA 2004;101:9774-9.
43. Vedhachalam C, Ghering AB, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC. ABCA1-induced cell surface binding sites for ApoA-I. Arterioscler Thromb Vasc Biol 2007;27:1603-9.
44. Vedhachalam C, Duong PT, Nickel M, Nguyen D, Dhanasekaran P, Saito H, et al. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid effux to apolipoprotein A-I and formation of high density lipoprotein particles. J Biol Chem 2007;282:25123-30.
45. Wang N, Ranalletta M, Matsuura F, Peng F, Tall AR. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass effux to HDL. Arterioscler Thromb Vasc Biol 2006;26:1310-6.
46. Tarr PT, Edwards PA. ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J Lipid Res 2008;49:169-82.
47. Bocharov AV, Baranova IN, Vishnyakova TG, Remaley AT, Csako G, Thomas F, et al. Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-infammatory cytokine responses in THP-1 monocyte cells. J Biol Chem 2004;279:36072-82.
48. Yamauchi Y, Hayashi M, Abe-Dohmae S, Yokoyama S. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J Biol Chem 2003;278:47890-7.
49. Sviridov D, Fidge N, Beaumier-Gallon G, Fielding C. Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae). Biochem J 2001;358:79-86.
50. Haidar B, Denis M, Marcil M, Krimbou L, Genest J Jr. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J Biol Chem 2004;279:9963-9.
51. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993;75:187-97.
52. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994;77:53-62.
53. Sato R. SREBPs: protein interaction and SREBPs. FEBS J 2009;276:622-7.
54. Shimano H. SREBPs: novel aspects of SREBPs in the regulation of lipid synthesis. FEBS J 2009;276:615.
55. Yuan HY, Kuang SY, Zheng X, Ling HY, Yang YB, Yan PK, et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin 2008;29:555-63.
56. Tuo QH, Liang L, Zhu BY, Cao X, Liao DF. Effect of Daxx on cholesterol accumulation in hepatic cells. World J Gastroenterol 2008;14:435-40.
57. He QZ, Zeng HC, Tuo QH, Zhu BY, Rang WQ, Tang XQ, et al. Daxx mediates oxidized low-density lipoprotein-induced cholesterol accumulation and apoptosis in macrophages by upregulating caveolin-1 expression. Prog Biochem Biophysic 2010; in publish.
58. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, et al. Control of cellular cholesterol effux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA 2000;97:12097-102.
59. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, et al. Regulation of absorption and ABC1-mediated effux of cholesterol by RXR heterodimers. Science 2000;289:1524-9.
60. Hu YW, Wang Q, Ma X, Li XX, Liu XH, Xiao J, et al. TGF-beta1 upregulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. J Atheroscler Thromb 2010;17:493-502.
61. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
62. Llaverias G, Vazquez-Carrera M, Sanchez RM, Noe V, Ciudad CJ, Laguna JC, et al. Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. J Lipid Res 2004;45:2015-24.
63. Ogata M, Tsujita M, Hossain MA, Akita N, Gonzalez FJ, Staels B, et al. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis 2009;205:413-9.
64. Ahmed RA, Murao K, Imachi H, Yu X, Li J, Wong NC, et al. Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes. Endocrine 2009;35:233-42.
65. Tao H, Aakula S, Abumrad NN, Hajri T. Peroxisome proliferatoractivated receptor gamma regulates the expression and function of very low density lipoprotein receptor. Am J Physiol Endocrinol Metab 2010;298: E68-79.
66. Ziouzenkova O, Plutzky J. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett 2008;582:32-8.
67. Lim HJ, Lee S, Lee KS, Park JH, Jang Y, Lee EJ, et al. PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs. Prostaglandins Other Lipid Mediat 2006;80:165-74.
68. Haraguchi G, Kobayashi Y, Brown ML, Tanaka A, Isobe M, Gianturco SH, et al. PPAR (alpha) and PPAR (gamma) activators suppress the monocyte-macrophage apoB-48 receptor. J Lipid Res 2003;44:1224-31.
69. Ditiatkovski M, Toh BH, Bobik A. GM-CSF defciency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-defcient mice. Arterioscler Thromb Vasc Biol 2006;26:2337-44.
70. Hu Q, Zhang XJ, Liu CX, Wang XP, Zhang Y. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-defcient mice. J Vasc Res 2010;47:69-79.
71. Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002;110:659-69.
72. Wolf G. Retinoic acid activation of peroxisome proliferation-activated receptor delta represses obesity and insulin resistance. Nutr Rev 2010;68:67-70.
73. Coll T, Rodriguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer X, et al. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome. Curr Mol Pharmacol 2009;2:46-55.
74. Parr RD, Martin GG, Hostetler HA, Schroeder ME, Mir KD, Kier AB, et al. A new N-terminal recognition domain in caveolin-1 interacts with sterol carrier protein-2 (SCP-2). Biochemistry 2007;46:8301-14.
75. Storey SM, Atshaves BP, McIntosh AL, Landrock KK, Martin GG, Huang H, et al. Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from primary cultured mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol 2010;299: G244-54.
76. Schroeder F, Huang H, McIntosh AL, Atshaves BP, Martin GG, Kier AB. Caveolin, sterol carrier protein-2, membrane cholesterol-rich microdomains and intracellular cholesterol traffcking. Subcell Biochem 2010;51:279-318.
77. Ma X, Hu YW, Mo ZC, Li XX, Liu XH, Xiao J, et al. NO-1886 upregulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. Cardiovasc Drugs Ther 2009;23:199-206.
78. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, et al. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 1999;261:547-50.
79. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 2001;98:5306-11.
80. Kujiraoka T, Nanjee MN, Oka T, Ito M, Nagano M, Cooke CJ, et al. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans. Arterioscler Thromb Vasc Biol 2003;23:1653-9.
81. Pikuleva IA. Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering. Expert Opin Drug Metab Toxicol 2008;4:1403-14.
82. Li T, Chen W, Chiang JY. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res 2007;48:373-84.
83. Bjorkhem I B K, Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995. p2073-2099.
84. Escher G, Krozowski Z, Croft KD, Sviridov D. Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol effux. J Biol Chem 2003;278:11015-9.
85. -/- mice is regulated by LPL activity and involves proteoglycans and SR-BI. J Lipid Res 2008;49:1553-61.
86. Lichtenstein L, Berbee JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL-and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol 2007;27:2420-7.
87. Yin W, Liao D, Wang Z, Xi S, Tsutsumi K, Koike T, et al. NO-1886 inhibits size of adipocytes, suppresses plasma levels of tumor necrosis factor-alpha and free fatty acids, improves glucose metabolism in high-fat/high-sucrose-fed miniature pigs. Pharmacol Res 2004;49:199-206.
88. Yin W, Liao D, Kusunoki M, Xi S, Tsutsumi K, Wang Z, et al. NO-1886 decreases ectopic lipid deposition and protects pancreatic beta cells in diet-induced diabetic swine. J Endocrinol 2004;180:399-408.
89. Jones MK, Catte A, Li L, Segrest JP. Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I. Biochemistry 2009;48:11196-210.
90. Kusunoki J, Aragane K, Kitamine T, Yamaura T, Ohnishi H. Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterifcation of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells. Nippon Yakurigaku Zasshi 1997;110:357-65.
91. Lei L, Xiong Y, Chen J, Yang JB, Wang Y, Yang XY, et al. TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation. J Lipid Res 2009;50:1057-67.
92. Deligny A, Denys A, Marcant A, Melchior A, Mazurier J, van Kuppevelt TH, et al. Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J Biol Chem 2010;285:1701-15.
93. Carreira RS, Lee Y, Ghochani M, Gustafsson AB, Gottlieb RA. Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells. Autophagy 2010;6:462-72.
94. Bonfls C, Bec N, Larroque C, Del Rio M, Gongora C, Pugniere M, et al. Cyclophilin A as negative regulator of apoptosis by sequestering cytochrome c. Biochem Biophys Res Commun 2010;393:325-30.
95. Kallen J, Walkinshaw MD. The X-ray structure of a tetrapeptide bound to the active site of human cyclophilin A. FEBS Lett 1992;300:286-90.
96. Takahashi N, Hayano T, Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989;337:473-5.
97. Ito J, Nagayasu Y, Kato K, Sato R, Yokoyama S. Apolipoprotein A-I induces translocation of cholesterol, phospholipid, and caveolin-1 to cytosol in rat astrocytes. J Biol Chem 2002;277:7929-35.
98. Persson J, Degerman E, Nilsson J, Lindholm MW. Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun 2007;363:1020-6.
99. Larigauderie G, Cuaz-Perolin C, Younes AB, Furman C, Lasselin C, Copin C, et al. Adipophilin increases triglyceride storage in human macro phages by stimulation of biosynthesis and inhibition of betaoxidation. Febs J 2006;273:3498-510.
100. Larigauderie G, Furman C, Jaye M, Lasselin C, Copin C, Fruchart JC, et al. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol 2004;24:504-10.
101. Bildirici I, Roh CR, Schaiff WT, Lewkowski BM, Nelson DM, Sadovsky Y. The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferatoractivated receptor-gamma/retinoid X receptor. J Clin Endocrinol Metab 2003;88:6056-62.
102. Zhao Y, Sparks DL, Marcel YL. Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fbroblasts. Studies with reconstituted sonicated lipoproteins. J Biol Chem 1996;271:25145-51.
103. Liu XH, Xiao J, Mo ZC, Yin K, Jiang J, Cui LB, et al. Contribution of D4-F to ABCA1 expression and cholesterol efflux in THP-1 macrophage-derived foam cells. J Cardiovasc Pharmacol 2010 July 9. doi: 10.1097/FJC.0b013e3181edaf69
104. Yancey PG, Kawashiri MA, Moore R, Glick JM, Williams DL, Connelly MA, et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI-and ABCA1-mediated cholesterol effux. J Lipid Res 2004;45:337-46.
105. Ronis MJ, Chen Y, Badeaux J, Badger TM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr 2009;139:1431-8.
106. Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, et al. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 longchain polyunsaturated fatty acid depletion. Biochim Biophys Acta 2009;1792:1080-6.
107. Smart EJ, De Rose RA, Farber SA. Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc Natl Acad Sci U S A 2004;101:3450-5.
108. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, Xu S, et al. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997;272:13242-9.
109. Uehara Y, Miura S, von Eckardstein A, Abe S, Fujii A, Matsuo Y, et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007;191:11-21.
110. Feng B, Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem 2002;277:43271-80.
111. Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, Ohashi R, et al. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol Cell Biol 2007;27:4248-60.
112. Duan LP, Wang HH, Wang DQ. Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol effux transporters Abcg5 and Abcg8 in mice. J Lipid Res 2004;45:1312-23.
113. Kusuhara H, Sugiyama Y. ATP-binding cassette, subfamily G (ABCG family). Pfugers Arch 2007;453:735-44.
114. Calpe-Berdiel L, Rotllan N, Fievet C, Roig R, Blanco-Vaca F, Escola-Gil JC. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res 2008;49:1904-11.
115. Seizer P, Schiemann S, Merz T, Daub K, Bigalke B, Stellos K, et al. CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis. Semin Thromb Hemost 2010;36:157-62.
116. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, Besler C, et al. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 2010. doi: 10.1093/eurheartj/ehq107.
117. Nakano A, Inoue N, Sato Y, Nishimichi N, Takikawa K, Fujita Y, et al. LOX-1 mediates vascular lipid retention under hypertensive state. J Hypertens 2010;28:1273-80.
118. Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr 2009;139:1700-6.
119. Parish S, Peto R, Palmer A, Clarke R, Lewington S, Offer A, et al. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. Eur Heart J 2009;30:2137-46.
120. Qi L, Liu S, Rifai N, Hunter D, Hu FB. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis 2007;192:204-10.
121. Horton JD, Shimomura I, Ikemoto S, Bashmakov Y, Hammer RE. Over expression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem 2003;278:36652-60.
122. Tamehiro N, Shigemoto-Mogami Y, Kakeya T, Okuhira K, Suzuki K, Sato R, et al. Sterol regulatory element-binding protein-2-and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status. J Biol Chem 2007;282:21090-9.
123. Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Biol Chem 2003;278:34114-8.
124. Masson D, Staels B, Gautier T, Desrumaux C, Athias A, Le Guern N, et al. Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse. J Lipid Res 2004;45:543-50.
125. Crestani M, De Fabiani E, Caruso D, Mitro N, Gilardi F, Vigil Chacon AB, et al. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport. Biochem Soc Trans 2004;32:92-6.
126. Briand F, Treguier M, Andre A, Grillot D, Issandou M, Ouguerram K, et al. Liver X receptor activation promotes macrophage-to-feces reverse choles terol transport in a dyslipidemic hamster model. J Lipid Res 2010;51:763-70.
127. Furnsinn C, Willson TM, Brunmair B. Peroxisome proliferatoractivated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport. Diabetologia 2007;50:8-17.
128. Ko MH, Puglielli L. The sterol carrier protein SCP-x/pro-SCP-2 gene has trans criptional activity and regulates the Alzheimer disease gamma-secretase. J Biol Chem 2007;282:19742-52.
129. Dyer DH, Wessely V, Forest KT, Lan Q. Three-dimensional structure/function analysis of SCP-2-like2 reveals differences among SCP-2 family members. J Lipid Res 2008;49:644-53.
130. Vikstedt R, Metso J, Hakala J, Olkkonen VM, Ehnholm C, Jauhiainen M. Cholesterol effux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. Biochemistry 2007;46:11979-86.
131. Saarela J, Metso J, Schneider WJ, Jauhiainen M. Avian phospholipid transfer protein causes HDL conversion without affecting cholesterol effux from macrophages. Biochim Biophys Acta 2009;1791:781-9.
132. Pahl MV, Ni Z, Sepassi L, Moradi H, Vaziri ND. Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD). Nephrol Dial Transplant 2009;24:2541-6.
133. Attia N, Nakbi A, Smaoui M, Chaaba R, Moulin P, Hammami S, et al. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol effux in type 2 diabetic subjects with coronary artery disease. Tohoku J Exp Med 2007;213:129-37.
134. Tchoua U, D'Souza W, Mukhamedova N, Blum D, Niesor E, Mizrahi J, et al. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport. Cardiovasc Res 2008;77:732-9.
135. Rensen PC, Havekes LM. Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport? Arterioscler Thromb Vasc Biol 2006;26:681-4.
136. Erickson RP, Larson-Thome K, Weberg L, Szybinska A, Mossakowska M, Styczynska M, et al. Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett 2008;447:153-7.
137. Shoji Y, Takahashi K, Ohta M, Kasai M, Kunishiro K, Kanda M, et al. Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities. Bioorg Med Chem 2009;17:6020-31.
138. Tanigawa H, Billheimer JT, Tohyama J, Fuki IV, Ng DS, Rothblat GH, et al. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo. Circulation 2009;120:160-9.
139. Franco M, Castro G, Romero L, Regalado JC, Medina A, Huesca-Gomez C, et al. Decreased activity of lecithin:cholesterol acyltransferase and hepatic lipase in chronic hypothyroid rats: implications for reverse cholesterol transport. Mol Cell Biochem 2003;246:51-6.
140. Gupta RP, Patrick K, Bell NH. Mutational analysis of CYP27A1: assessment of 27-hydroxylation of cholesterol and 25-hydroxylation of vitamin D. Metabolism 2007;56:1248-55.
141. von Bahr S, Movin T, Papadogiannakis N, Pikuleva I, Ronnow P, Diczfalusy U, et al. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). Arterioscler Thromb Vasc Biol 2002;22:1129-35.
142. Nuotio K, Isoviita PM, Saksi J, Ijas P, Pitkaniemi J, Sonninen R, et al. Adipophilin expression is increased in symptomatic carotid atherosclerosis: correlation with red blood cells and cholesterol crystals. Stroke 2007;38:1791-8.
143. Hascalovici JR, Song W, Vaya J, Khatib S, Fuhrman B, Aviram M, et al. Impact of heme oxygenase-1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia. J Neurochem 2009;108:72-81.
144. Wong J, Quinn CM, Brown AJ. SREBP-2 positively regulates transcription of the cholesterol effux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem J 2006;400:485-91.
145. Patel R, Soulages JL, Wells MA, Arrese EL. cAMP-dependent protein kinase of Manduca sexta phosphorylates but does not activate the fat body triglyceride lipase. Insect Biochem Mol Biol 2004;34:1269-79.
146. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, et al. Peripheraltype benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol Endocrinol 2005;19:540-4.